L-DOPA CAS:59-92-7
L-DOPA is primarily used in the treatment of Parkinson's disease to alleviate symptoms such as tremors, stiffness, and difficulty with movement. It crosses the blood-brain barrier and is converted into dopamine, helping to restore depleted dopamine levels in the brains of individuals with Parkinson's disease. This can lead to improved motor function and overall quality of life for those affected by the condition. Additionally, L-DOPA has been studied for its potential role in supporting mood and cognitive function, given the influence of dopamine in these areas. Some individuals may consider incorporating L-DOPA supplements into their wellness regimens to explore potential benefits for mental well-being. When using L-DOPA, it is crucial to do so under the guidance of a healthcare professional, especially when managing neurological disorders or considering it for other health-related purposes. Determining appropriate dosages and monitoring for potential side effects or interactions is essential to ensure safe and effective use. Comprehensive discussions with qualified experts can provide insights into personalized recommendations based on individual health contexts. While L-DOPA presents potential benefits for Parkinson's disease management and potential implications for mental well-being, seeking professional guidance and adhering to recommended usage guidelines are vital to maximize its potential benefits and mitigate any associated risks.
Composition | C9H11NO4 |
Assay | 99% |
Appearance | white powder |
CAS No. | 59-92-7 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |